Ari A Gershon

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Transcranial magnetic stimulation in the treatment of depression
    Ari A Gershon
    Psychiatry Division, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Am J Psychiatry 160:835-45. 2003
  2. ncbi request reprint Dopamine D2-like receptors and the antidepressant response
    Ari A Gershon
    Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Biol Psychiatry 61:145-53. 2007
  3. doi request reprint A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder
    Mark Weiser
    Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Schizophr Res 138:35-8. 2012
  4. doi request reprint An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia
    Guy Orr
    Department of Psychiatry Sheba Medical Center, Tel Hashomer, Israel
    J Nerv Ment Dis 196:496-500. 2008

Detail Information

Publications4

  1. ncbi request reprint Transcranial magnetic stimulation in the treatment of depression
    Ari A Gershon
    Psychiatry Division, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Am J Psychiatry 160:835-45. 2003
    ..The authors evaluate evidence from the last decade supporting a possible role for TMS in the treatment of depression and explore clinical and technical considerations that might bear on treatment success...
  2. ncbi request reprint Dopamine D2-like receptors and the antidepressant response
    Ari A Gershon
    Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Biol Psychiatry 61:145-53. 2007
    ....
  3. doi request reprint A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder
    Mark Weiser
    Division of Psychiatry, Chaim Sheba Medical Center, Tel Hashomer, Israel
    Schizophr Res 138:35-8. 2012
    ..13) and in clinical and cognitive measures. No difference was observed between groups in primary (t=0.01, p=0.992) or secondary outcome measures. These findings do not support allopurinol as a treatment for schizophrenia...
  4. doi request reprint An open-label pilot study to evaluate the efficacy of sildenafil citrate in middle-aged men with late-onset dysthymia
    Guy Orr
    Department of Psychiatry Sheba Medical Center, Tel Hashomer, Israel
    J Nerv Ment Dis 196:496-500. 2008
    ..Sildenafil citrate might have an antidepressant effect on late onset DD, that is not attributable to improvement in erectile function. Possible explanations for this effect are offered. Larger placebo controlled studies are warranted...